What’s on the horizon to tackle unmet needs in recurrent/metastatic SCCHN?

Поділитися
Вставка
  • Опубліковано 3 бер 2024
  • Hear insights from experts: Dr Aline Chaves, Prof. Makoto Tahara and Dr Ranee Mehra explore the rationale and latest data for immunotherapy-based and targeted treatments in development for recurrent/metastatic SCCHN.
    Watch now: touchoncologyime.org/future-t...
    This activity is funded by an independent medical education grant from Seagen Inc. and Genmab US, Inc., and is jointly provided by USF Health and touchIME.

КОМЕНТАРІ •